Expression of the melanoma antigen-encoding gene in human lung cancer

Journal of Surgical Oncology

Volumn 67, Issue 2, 1998, Pages 126-129

  Yoshimatsu, Takashi ^a   Yoshino, Ichiro ^a   Ohgami, Akira ^a   Takenoyama, Mitsuhiro ^a   Hanagiri, Takeshi ^a   Nomoto, Kikuo ^b   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Immunotherapy; Lung cancer; MAGE gene; Tumor rejection antigen

Indexed keywords

ARTICLE; CANCER IMMUNOTHERAPY; GENE EXPRESSION; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; RNA, MESSENGER;

EID: 0031888005     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199802)67:2<126::AID-JSO10>3.0.CO;2-1     Document Type: Article

References (24)

1. Van der Bruggen P, Traversari C, Chomez P, et al.: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-1647.
2. Brichard V, Van Pel A, Wolfel T, et al.: The tyrosinase gene codes for an antigen recognized by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-495.
3. Kawakami Y, Eliyahu S, Delgado CH, et al.: Cloning of the gene coding for shared human melanoma antigen recognized by autologous T cells infiltrating into tumors. Proc Natl Acad Sci USA 1994;91:3315-3515.
4. Kawakami Y, Eliyahu S, Delgado CH, et al.: Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-6462.
5. Gaugler B, Van den Eynde, Van der Bruggen, et al.: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic lymphocytes. J Exp Med 1994;179:921-930.
6. Van der Bruggen, Bastin J, Gajewski T, et al.: A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 1994;24:3038-3043.
7. Brasseur F, Marchand M, Vanwijck R, et al.: Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 1992;52:839-841.
8. Patard JJ, Brasseur F, Gil-Diez S, et al.: Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 1995;64:60-64.
9. Van Pel A, Van der Bruggen P, Coulie PG, et al.: Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 1995;145:229-250.
10. Inoue H, Mori M, Honda M, et al.: The expression of tumorrejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterol 1995;109:1522-1525.
11. Inoue H, Mori M, Li J, et al.: Human esophageal carcinoma frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer 1995;63:523-526.
12. Rimoldi D, Romero P, Carrel S: The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993;54:527-528.
13. Takahashi K, Shichijo S, Noguchi M, et al.: Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995;55:3478-3482.
14. De Plaen, Arden K, Traverari C, et al.: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-369.
15. Becker JC, Gillitzer R, Bröcker E-B: A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 1994;58:346-348.
16. Marchard M, Weynants P, Rankin E, et al.: Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995;63:883-887.
17. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225-233.
18. The World Health Organization. Histological typing of lung tumors. Am J Clin Pathol 1982;57:471-476.
19. Weynants P, Lethe B, Brasseur F, et al.: Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 1994;56: 826-829.
20. de Smet C, Lurquin C, Van der Bruggen, et al.: Sequence and expression pattern of the human MAGE-2 gene. Immunogenetics 1994;39:121-129.
21. Peoples GE, Goedegebuure PS, Smith R, et al.: Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci USA 1995;92: 432-436.
22. Dong R, Kimura A, Okubo R, et al.: HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 1992;35:165-172.
23. Traversari C, Van der Bruggen P, Luescher IF, et al.: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992;176:1453-1457.
24. Van der Bruggen P, Szikora J-P, Boẽl P, et al.: Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol 1994;24:2134-2140.